BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19652887)

  • 1. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1.
    Lv B; Wang H; Tang Y; Fan Z; Xiao X; Chen F
    Thromb Haemost; 2009 Aug; 102(2):352-9. PubMed ID: 19652887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.
    Huang W; Liu Y; Li L; Zhang R; Liu W; Wu J; Mao E; Tang Y
    Inflammation; 2012 Feb; 35(1):350-62. PubMed ID: 21494799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
    Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
    J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.
    Bea F; Puolakkainen MH; McMillen T; Hudson FN; Mackman N; Kuo CC; Campbell LA; Rosenfeld ME
    Circ Res; 2003 Mar; 92(4):394-401. PubMed ID: 12600889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
    Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway.
    Yang J; Huang C; Yang J; Jiang H; Ding J
    Mol Cell Biochem; 2010 Dec; 345(1-2):189-95. PubMed ID: 20714791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-κB and AP-1.
    Yang X; Li L; Liu J; Lv B; Chen F
    Thromb Res; 2016 Jan; 137():211-218. PubMed ID: 26476743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner.
    Li MJ; Li F; Xu J; Liu YD; Hu T; Chen JT
    Biosci Rep; 2016 Jan; 36(1):e00300. PubMed ID: 26744383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 protein interacts with multiple Toll-like receptors.
    Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
    Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.
    Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N
    Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
    Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products - membrane type1 matrix metalloproteinase axis regulates tissue factor expression via RhoA and Rac1 activation in high-mobility group box-1 stimulated endothelial cells.
    Sugimoto K; Ohkawara H; Nakamura Y; Takuwa Y; Ishibashi T; Takeishi Y
    PLoS One; 2014; 9(12):e114429. PubMed ID: 25490770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells.
    Jiang Y; Steinle JJ
    Growth Factors; 2018 Aug; 36(3-4):164-171. PubMed ID: 31084273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning with high mobility group box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance.
    Robert SM; Sjodin H; Fink MP; Aneja RK
    J Immunother; 2010 Sep; 33(7):663-71. PubMed ID: 20664360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway.
    Shang D; Peng T; Gou S; Li Y; Wu H; Wang C; Yang Z
    Sci Rep; 2016 Aug; 6():32180. PubMed ID: 27572515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE-dependent NF-kB inflammation processes in the capsule of frozen shoulders.
    Yano T; Hagiwara Y; Ando A; Kanazawa K; Koide M; Sekiguchi T; Itaya N; Onoki T; Suzuki K; Tsuchiya M; Sogi Y; Yabe Y; Itoi E
    J Shoulder Elbow Surg; 2020 Sep; 29(9):1884-1891. PubMed ID: 32279986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.
    Kokkola R; Andersson A; Mullins G; Ostberg T; Treutiger CJ; Arnold B; Nawroth P; Andersson U; Harris RA; Harris HE
    Scand J Immunol; 2005 Jan; 61(1):1-9. PubMed ID: 15644117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of high mobility group box 1 (HMGB1) in cultured human periodontal ligament cells].
    Hasegawa N
    Kokubyo Gakkai Zasshi; 2008 Oct; 75(3):155-61. PubMed ID: 19044016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.
    Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q
    PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.